DE3135305C2 - Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen - Google Patents

Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen

Info

Publication number
DE3135305C2
DE3135305C2 DE3135305A DE3135305A DE3135305C2 DE 3135305 C2 DE3135305 C2 DE 3135305C2 DE 3135305 A DE3135305 A DE 3135305A DE 3135305 A DE3135305 A DE 3135305A DE 3135305 C2 DE3135305 C2 DE 3135305C2
Authority
DE
Germany
Prior art keywords
acid
acetate
ergolinyl
ergoline
lead
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3135305A
Other languages
German (de)
English (en)
Other versions
DE3135305A1 (de
Inventor
Gregor Dr. 1000 Berlin Haffer
Gerhard Dr. Sauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE3135305A priority Critical patent/DE3135305C2/de
Priority to SU823470940A priority patent/SU1272988A3/ru
Priority to DK368382A priority patent/DK161646C/da
Priority to EP82730112A priority patent/EP0074921B1/en
Priority to AT82730112T priority patent/ATE11289T1/de
Priority to DE8282730112T priority patent/DE3261963D1/de
Priority to IL66679A priority patent/IL66679A/xx
Priority to DD82242909A priority patent/DD203544A5/de
Priority to AU87863/82A priority patent/AU555576B2/en
Priority to GR69181A priority patent/GR76897B/el
Priority to ES515428A priority patent/ES8305361A1/es
Priority to HU822824A priority patent/HU186969B/hu
Priority to CA000410636A priority patent/CA1175813A/en
Priority to JP57152871A priority patent/JPS5855483A/ja
Priority to YU01992/82A priority patent/YU199282A/xx
Priority to CS826422A priority patent/CS241122B2/cs
Priority to IE2156/82A priority patent/IE53437B1/en
Publication of DE3135305A1 publication Critical patent/DE3135305A1/de
Application granted granted Critical
Publication of DE3135305C2 publication Critical patent/DE3135305C2/de
Priority to US06/808,804 priority patent/US4748248A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3135305A 1981-09-03 1981-09-03 Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen Expired DE3135305C2 (de)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DE3135305A DE3135305C2 (de) 1981-09-03 1981-09-03 Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
SU823470940A SU1272988A3 (ru) 1981-09-03 1982-08-03 Способ получени эрголинов или их физиологически приемлемых солей
DK368382A DK161646C (da) 1981-09-03 1982-08-17 Fremgangsmaade til fremstilling af ergolinderivater og farmaceutisk acceptable salte heraf
EP82730112A EP0074921B1 (en) 1981-09-03 1982-08-23 Process for the preparation of ergoline derivatives
AT82730112T ATE11289T1 (de) 1981-09-03 1982-08-23 Verfahren zur herstellung von ergolinderivaten.
DE8282730112T DE3261963D1 (en) 1981-09-03 1982-08-23 Process for the preparation of ergoline derivatives
IL66679A IL66679A (en) 1981-09-03 1982-08-30 Process for the preparation or 6-alkyl-8-amino-(or 3,3-di-alkylureido)ergoline derivatives
AU87863/82A AU555576B2 (en) 1981-09-03 1982-08-31 Process for preparation of ergoline derivatives
DD82242909A DD203544A5 (de) 1981-09-03 1982-08-31 Verfahren zur herstellung von ergolinderivaten
GR69181A GR76897B (OSRAM) 1981-09-03 1982-09-01
ES515428A ES8305361A1 (es) 1981-09-03 1982-09-01 "procedimiento para la preparacion de ergolinas".
CA000410636A CA1175813A (en) 1981-09-03 1982-09-02 Process for the preparation of ergoline derivatives
HU822824A HU186969B (en) 1981-09-03 1982-09-02 Process for producing ergoline derivatives
JP57152871A JPS5855483A (ja) 1981-09-03 1982-09-03 エルゴリン誘導体の製法
YU01992/82A YU199282A (en) 1981-09-03 1982-09-03 Process for producing ergoline derivatives
CS826422A CS241122B2 (en) 1981-09-03 1982-09-03 Method of ergoline derivatives production
IE2156/82A IE53437B1 (en) 1981-09-03 1982-09-03 Process for the preparation of ergoline derivatives
US06/808,804 US4748248A (en) 1981-09-03 1985-12-13 Process for the preparation of ergoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3135305A DE3135305C2 (de) 1981-09-03 1981-09-03 Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen

Publications (2)

Publication Number Publication Date
DE3135305A1 DE3135305A1 (de) 1983-03-10
DE3135305C2 true DE3135305C2 (de) 1983-07-21

Family

ID=6141023

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3135305A Expired DE3135305C2 (de) 1981-09-03 1981-09-03 Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
DE8282730112T Expired DE3261963D1 (en) 1981-09-03 1982-08-23 Process for the preparation of ergoline derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8282730112T Expired DE3261963D1 (en) 1981-09-03 1982-08-23 Process for the preparation of ergoline derivatives

Country Status (17)

Country Link
US (1) US4748248A (OSRAM)
EP (1) EP0074921B1 (OSRAM)
JP (1) JPS5855483A (OSRAM)
AT (1) ATE11289T1 (OSRAM)
AU (1) AU555576B2 (OSRAM)
CA (1) CA1175813A (OSRAM)
CS (1) CS241122B2 (OSRAM)
DD (1) DD203544A5 (OSRAM)
DE (2) DE3135305C2 (OSRAM)
DK (1) DK161646C (OSRAM)
ES (1) ES8305361A1 (OSRAM)
GR (1) GR76897B (OSRAM)
HU (1) HU186969B (OSRAM)
IE (1) IE53437B1 (OSRAM)
IL (1) IL66679A (OSRAM)
SU (1) SU1272988A3 (OSRAM)
YU (1) YU199282A (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
HU195810B (en) * 1984-12-24 1988-07-28 Sandoz Ag Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
US20060171795A1 (en) * 2005-01-28 2006-08-03 Cromwell Stephen D Substantial embedment of metallic debris
JP2010119349A (ja) * 2008-11-20 2010-06-03 Shinichi Okamoto 即席のパンなどの穀物粉加工食品の製造方法
BR112017015510A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
CN113149982A (zh) 2015-01-20 2021-07-23 Xoc制药股份有限公司 麦角灵化合物及其用途
JP2020522504A (ja) 2017-06-01 2020-07-30 エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc 多環式化合物およびそれらの用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS5855483A (ja) 1983-04-01
CS642282A2 (en) 1985-07-16
DK161646C (da) 1992-01-06
CS241122B2 (en) 1986-03-13
ES515428A0 (es) 1983-05-01
ES8305361A1 (es) 1983-05-01
IE822156L (en) 1983-03-03
IL66679A (en) 1986-04-29
DE3261963D1 (en) 1985-02-28
YU199282A (en) 1985-03-20
AU555576B2 (en) 1986-10-02
ATE11289T1 (de) 1985-02-15
SU1272988A3 (ru) 1986-11-23
DK161646B (da) 1991-07-29
DE3135305A1 (de) 1983-03-10
DK368382A (da) 1983-03-04
EP0074921A1 (en) 1983-03-23
EP0074921B1 (en) 1985-01-16
AU8786382A (en) 1983-03-10
JPH0239511B2 (OSRAM) 1990-09-05
GR76897B (OSRAM) 1984-09-04
IE53437B1 (en) 1988-11-09
HU186969B (en) 1985-10-28
CA1175813A (en) 1984-10-09
IL66679A0 (en) 1982-12-31
DD203544A5 (de) 1983-10-26
US4748248A (en) 1988-05-31

Similar Documents

Publication Publication Date Title
EP0021206B1 (de) Neue (Ergolin-yl)-N', N'-diäthylharnstoff-Derivate, ihre Herstellung und sie enthaltende Arzneimittel
DD202027A5 (de) Verfahren zur herstellung von neuen (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivaten
DE3151912A1 (de) Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE2017560C2 (de) Verfahren zur Herstellung von Peptidgruppen enthaltenden Lysergsäurederivaten
EP0118848B1 (de) Neue Ergolin-Derivate, Verfahren zu ihrer Herstellung sowie Verwendung als Arzneimittel
DE3135305A1 (de) Verfahren zur herstellung von 8-ergolinyl-harnstoffen
DE69932938T2 (de) Verfahren zur herstellung eiens naphthyridincarbonsäurederivate (methansulfonat-sesquihydrat)
DD156973A5 (de) Verfahren zur herstellung von 8 alpha-substituierten 6-methyl-10 alpha-h-ergolinen
DE3308719A1 (de) 1-substituierte n-(8(alpha)-ergolinyl)-n'.n'-diethylharnstoffe, ihre herstellung und pharmakologische verwendung
DE3340025C2 (de) Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
DE4123587A1 (de) 2,14-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln
DE3413657A1 (de) Neue ergoline
DE2554000A1 (de) 6-methyl-8-(substituierte)methylergoline
DE3620293A1 (de) 1-und/oder 2-substituierte ergolinderivate
DE3913756A1 (de) 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
EP0427827A1 (de) 8-g(a)-ACYLAMINO-ERGOLINE, IHRE HERSTELLUNG UND VERWENDUNG ALS ARZNEIMITTEL.
DE3413659A1 (de) Neue 2-substituierte ergolin-derivate
DE1795701B2 (de) Alpha- substituierte benzylpenicillinsaeureester
DE2459630A1 (de) Verfahren zur herstellung von pyrimidinoaminomethylergolinderivaten
DE2407904A1 (de) D-2-subst.-6-alkyl-8-subst.-ergoline und verfahren zu ihrer herstellung
DE2656093A1 (de) Neue d-6-alkyl-8-cyanomethylergolin-i-derivate, deren salze, verfahren zu ihrer herstellung und pharmazeutische mittel
DE2728870C2 (de) Verfahren zur Herstellung von D-Penicillamin und dessen Salzen
DE2709838A1 (de) Verfahren zur herstellung von 5-fluoruracil-derivaten mit einem katalysator
AT378190B (de) Verfahren zur herstellung von neuen oximen
DE3342325A1 (de) 3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6- dioxopurin-7-acetyl)-8-(2-phenylethyl)-1-oxa-3,8-diazaspiro-(4.5)decan-2-on, verfahren zu dessen herstellung und dieses enthaltende arzneimittel

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee